Functional Differences of Very-Low-Density Lipoprotein Receptor Splice Variants in Regulating Wnt Signaling

REFERENCES

• MacDonald BT, Tamai K, He X. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9–26. http://dx.doi.org/10.1016/j.devcel.2009.06.016.
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. 2012. Wnt/beta-catenin signaling and disease. Cell 149:1192–1205. http://dx.doi.org/10.1016/j.cell.2012.05.012.
   PubMed Web of Science ®Google Scholar
• Bergmann MW. 2010. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res 107:1198–1208. http://dx.doi.org/10.1161/CIRCRESAHA.110.223768.
   PubMed Web of Science ®Google Scholar
• Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS, Wolf D, Riffel J, Bauer A, Katus HA, Hardt SE. 2010. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension 55:939–945. http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.141127.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu Y, Zhou T, Zhou KK, Mott R, Wu M, Boulton M, Lyons TJ, Gao G, Ma JX. 2009. Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 175:2676–2685. http://dx.doi.org/10.2353/ajpath.2009.080945.
   PubMedGoogle Scholar
• Zhou T, He X, Cheng R, Zhang B, Zhang RR, Chen Y, Takahashi Y, Murray AR, Lee K, Gao G, Ma JX. 2012. Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 55:255–266. http://dx.doi.org/10.1007/s00125-011-2314-2.
   PubMed Web of Science ®Google Scholar
• Dieckmann M, Dietrich MF, Herz J. 2010. Lipoprotein receptors—an evolutionarily ancient multifunctional receptor family. Biol Chem 391:1341–1363. http://dx.doi.org/10.1515/BC.2010.129.
   PubMedGoogle Scholar
• Hussain MM, Strickland DK, Bakillah A. 1999. The mammalian low-density lipoprotein receptor family. Annu Rev Nutr 19:141–172. http://dx.doi.org/10.1146/annurev.nutr.19.1.141.
   PubMed Web of Science ®Google Scholar
• Argraves WS. 2001. Members of the low density lipoprotein receptor family control diverse physiological processes. Front Biosci 6:D406–D416.
   PubMedGoogle Scholar
• Tissir F, Goffinet AM. 2003. Reelin and brain development. Nat Rev Neurosci 4:496–505. http://dx.doi.org/10.1038/nrn1113.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu Y, Lu K, Flannery JG, Ma J-X. 2007. Very low density lipoprotein receptor, a negative regulator of the Wnt signaling pathway and choroidal neovascularization. J Biol Chem 282:34420–34428. http://dx.doi.org/10.1074/jbc.M611289200.
   PubMedGoogle Scholar
• Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J. 1995. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci U S A 92:8453–8457. http://dx.doi.org/10.1073/pnas.92.18.8453.
   PubMed Web of Science ®Google Scholar
• Hu W, Jiang A, Liang J, Meng H, Chang B, Gao H, Qiao X. 2008. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 49:407–415. http://dx.doi.org/10.1167/iovs.07-0870.
   PubMed Web of Science ®Google Scholar
• Li C, Huang Z, Kingsley R, Zhou X, Li F, Parke DW, II, Cao W. 2007. Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation. Arch Ophthalmol 125:795–803. http://dx.doi.org/10.1001/archopht.125.6.795.
   PubMedGoogle Scholar
• Jiang A, Hu W, Meng H, Gao H, Qiao X. 2009. Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis. Invest Ophthalmol Vis Sci 50:844–850. http://dx.doi.org/10.1167/iovs.08-2447.
   PubMedGoogle Scholar
• Lee K, Shin Y, Cheng R, Park K, Hu Y, McBride J, He X, Takahashi Y, Ma JX. 2014. Receptor heterodimerization as a novel mechanism for the regulation of Wnt/beta-catenin signaling. J Cell Sci 127:4857–4869. http://dx.doi.org/10.1242/jcs.149302.
   PubMedGoogle Scholar
• Iijima H, Miyazawa M, Sakai J, Magoori K, Ito MR, Suzuki H, Nose M, Kawarabayasi Y, Yamamoto TT. 1998. Expression and characterization of a very low density lipoprotein receptor variant lacking the O-linked sugar region generated by alternative splicing. J Biochem 124:747–755. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022175.
   PubMedGoogle Scholar
• Sakai K, Tiebel O, Ljungberg MC, Sullivan M, Lee HJ, Terashima T, Li R, Kobayashi K, Lu HC, Chan L, Oka K. 2009. A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of ApoE containing lipoproteins. Brain Res 1276:11–21. http://dx.doi.org/10.1016/j.brainres.2009.04.030.
   PubMedGoogle Scholar
• Chen T, Wu F, Chen FM, Tian J, Qu S. 2005. Variations of very low-density lipoprotein receptor subtype expression in gastrointestinal adenocarcinoma cells with various differentiations. World J Gastroenterol 11:2817–2821. http://dx.doi.org/10.3748/wjg.v11.i18.2817.
   PubMedGoogle Scholar
• Yang P, Liu Z, Wang H, Tian J, Li Y, Zong Y, Qu S. 2009. Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration. Life Sci 84:402–408. http://dx.doi.org/10.1016/j.lfs.2008.12.020.
   PubMed Web of Science ®Google Scholar
• Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Merluzzi VJ. 1990. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 344:70–72. http://dx.doi.org/10.1038/344070a0.
   PubMed Web of Science ®Google Scholar
• Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. 1991. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 147:4398–4401.
   Google Scholar
• Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. 2001. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98:1904–1913. http://dx.doi.org/10.1182/blood.V98.6.1904.
   PubMed Web of Science ®Google Scholar
• Magrane J, Casaroli-Marano RP, Reina M, Gafvels M, Vilaro S. 1999. The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell. FEBS Lett 451:56–62. http://dx.doi.org/10.1016/S0014-5793(99)00494-9.
   PubMedGoogle Scholar
• Bollin F, Dechavanne V, Chevalet L. 2011. Design of experiment in CHO and HEK transient transfection condition optimization. Protein Expr Purif 78:61–68. http://dx.doi.org/10.1016/j.pep.2011.02.008.
   PubMed Web of Science ®Google Scholar
• Wu YQ, Notario V, Chader GJ, Becerra SP. 1995. Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. Protein Expr Purif 6:447–456. http://dx.doi.org/10.1006/prep.1995.1060.
   PubMedGoogle Scholar
• McBride JD, Jenkins AJ, Liu X, Zhang B, Lee K, Berry WL, Janknecht R, Griffin CT, Aston CE, Lyons TJ, Tomasek JJ, Ma JX. 2014. Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling. J Invest Dermatol 134:1725–1734. http://dx.doi.org/10.1038/jid.2014.40.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Chen Q, Rajala RV, Ma JX. 2015. MicroRNA-184 modulates canonical Wnt signaling through the regulation of frizzled-7 expression in the retina with ischemia-induced neovascularization. FEBS Lett 589:1143–1149. http://dx.doi.org/10.1016/j.febslet.2015.03.010.
   PubMedGoogle Scholar
• Murray AR, Chen Q, Takahashi Y, Zhou KK, Park K, Ma JX. 2013. MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. Invest Ophthalmol Vis Sci 54:1689–1697. http://dx.doi.org/10.1167/iovs.12-10921.
   PubMed Web of Science ®Google Scholar
• Wang Z, Cheng R, Lee K, Tyagi P, Ding L, Kompella UB, Chen J, Xu X, Ma J-X. 2015. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization. Arterioscler Thromb Vasc Biol 35:855–864. http://dx.doi.org/10.1161/ATVBAHA.114.304627.
   PubMedGoogle Scholar
• Marlovits TC, Abrahamsberg C, Blaas D. 1998. Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection. J Virol 72:10246–10250.
   PubMedGoogle Scholar
• Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J. 2002. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22:1184–1193. http://dx.doi.org/10.1128/MCB.22.4.1184-1193.2002.
   PubMed Web of Science ®Google Scholar
• Kingsley DM, Kozarsky KF, Hobbie L, Krieger M. 1986. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant. Cell 44:749–759. http://dx.doi.org/10.1016/0092-8674(86)90841-X.
   PubMed Web of Science ®Google Scholar
• Shen GM, Zhao YZ, Chen MT, Zhang FL, Liu XL, Wang Y, Liu CZ, Yu J, Zhang JW. 2012. Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia. Biochem J 441:675–683. http://dx.doi.org/10.1042/BJ20111377.
   PubMedGoogle Scholar
• Arden GB, Sivaprasad S. 2011. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 7:291–304. http://dx.doi.org/10.2174/157339911797415620.
   PubMedGoogle Scholar
• Nyengaard JR, Ido Y, Kilo C, Williamson JR. 2004. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes 53:2931–2938. http://dx.doi.org/10.2337/diabetes.53.11.2931.
   PubMedGoogle Scholar
• Wang J, Takeuchi T, Tanaka S, Kubo SK, Kayo T, Lu D, Takata K, Koizumi A, Izumi T. 1999. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103:27–37. http://dx.doi.org/10.1172/JCI4431.
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Kayo T, Ikeda T, Koizumi A. 1997. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46:887–894.
   PubMed Web of Science ®Google Scholar
• Chua SC, Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. 1996. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994–996. http://dx.doi.org/10.1126/science.271.5251.994.
   PubMed Web of Science ®Google Scholar
• Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, Sapieha P, Hua J, Hatton CJ, Juan AM, Aderman CM, Willett KL, Guerin KI, Mammoto A, Campbell M, Smith LE. 2011. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation 124:1871–1881. http://dx.doi.org/10.1161/CIRCULATIONAHA.111.040337.
   PubMed Web of Science ®Google Scholar
• Dorrell MI, Aguilar E, Jacobson R, Yanes O, Gariano R, Heckenlively J, Banin E, Ramirez GA, Gasmi M, Bird A, Siuzdak G, Friedlander M. 2009. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J Clin Invest 119:611–623. http://dx.doi.org/10.1172/JCI35977.
   PubMedGoogle Scholar
• Liu Q, Zhang J, Tran H, Verbeek MM, Reiss K, Estus S, Bu G. 2009. LRP1 shedding in human brain: roles of ADAM10 and ADAM17. Mol Neurodegener 4:17. http://dx.doi.org/10.1186/1750-1326-4-17.
   PubMedGoogle Scholar
• Arribas J, Massague J. 1995. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J Cell Biol 128:433–441. http://dx.doi.org/10.1083/jcb.128.3.433.
   PubMed Web of Science ®Google Scholar
• Arribas J, Lopez-Casillas F, Massague J. 1997. Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding. J Biol Chem 272:17160–17165. http://dx.doi.org/10.1074/jbc.272.27.17160.
   PubMedGoogle Scholar
• Garton KJ, Gough PJ, Philalay J, Wille PT, Blobel CP, Whitehead RH, Dempsey PJ, Raines EW. 2003. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 278:37459–37464. http://dx.doi.org/10.1074/jbc.M305877200.
   PubMed Web of Science ®Google Scholar
• Varela-Nallar L, Rojas-Abalos M, Abbott AC, Moya EA, Iturriaga R, Inestrosa NC. 2014. Chronic hypoxia induces the activation of the Wnt/beta-catenin signaling pathway and stimulates hippocampal neurogenesis in wild-type and APPswe-PS1DeltaE9 transgenic mice in vivo. Front Cell Neurosci 8:17. http://dx.doi.org/10.3389/fncel.2014.00017.
   PubMed Web of Science ®Google Scholar
• Mazumdar J, O'Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein PS, Simon MC. 2010. O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 12:1007–1013. http://dx.doi.org/10.1038/ncb2102.
   PubMed Web of Science ®Google Scholar
• Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK. 2005. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218. http://dx.doi.org/10.1167/iovs.04-1340.
   PubMed Web of Science ®Google Scholar
• Midena E, Segato T, Radin S, di Giorgio G, Meneghini F, Piermarocchi S, Belloni AS. 1989. Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res 21:106–111.
   Google Scholar
• Tadayoni R, Paques M, Gaudric A, Vicaut E. 2003. Erythrocyte and leukocyte dynamics in the retinal capillaries of diabetic mice. Exp Eye Res 77:497–504. http://dx.doi.org/10.1016/S0014-4835(03)00155-6.
   PubMed Web of Science ®Google Scholar
• Wyne KL, Pathak K, Seabra MC, Hobbs HH. 1996. Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol 16:407–415. http://dx.doi.org/10.1161/01.ATV.16.3.407.
   PubMedGoogle Scholar